Pathogenic microorganisms have been a serious threat to human life and have become a public health problem of global concern. However, in the actual treatment there is a lack of efficient antimicrobial strategies which do not easily develop drug resistance; this can lead to inaccurate drug treatment that worsens the infection and even threatens life. With the emergence of a variety of drug-resistant bacteria and fungi, photodynamic therapy has gradually become one of the most promising treatment methods for drug-resistant bacteria infection; this is because it is controllable, non-invasive, and not prone to cause the development of drug resistance. Organic conjugated polymers that possess high fluorescence intensity, a large molar extinction coefficient, excellent light stability, an adjustable energy band, easy modification, good biocompatibility, and the ability to photosensitize oxygen to produce reactive oxygen species have been widely used in the fields of solar cells, highly sensitive detection systems, biological imaging, and anti-cancer and anti-microbial treatment. Photodynamic therapy is non-invasive and has high temporal and spatial resolution and is a highly effective antimicrobial treatment that does not easily induce drug resistance; it has also stimulated the scientific research enthusiasm of researchers and has become a research hotspot in the antimicrobial field. In this review, the photodynamic antibacterial applications of conjugated polymers with different structure types are summarized, and their development directions are considered.

Photocatalysis is a powerful strategy to address energy and environmental concerns. Sulfur-doped BiOCl was prepared through a facial hydrothermal method to improve the photocatalytic performance. Experimental results and theoretical calculations demonstrated that the band structure of the sulfur-doped BiOCl was optimally regulated and the light absorption range was expanded. It showed excellent visible-light photocatalytic water oxidation properties with a rate of 141.7 μmol h⁻¹ g⁻¹ (almost 44 times of that of the commercial BiOCl) with Pt as co-catalyst.